These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Clinical assessment of Zyplast Implant: a year of experience for soft tissue contour correction. Elson ML J Am Acad Dermatol; 1988 Apr; 18(4 Pt 1):707-13. PubMed ID: 3372763 [TBL] [Abstract][Full Text] [Related]
25. Disseminated and recurrent sarcoid-like granulomatous panniculitis due to bovine collagen injection. García-Domingo MI; Alijotas-Reig J; Cisteró-Bahima A; Tresserra F; Enrique E J Investig Allergol Clin Immunol; 2000; 10(2):107-9. PubMed ID: 10880001 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of artecoll polymethylmethacrylate implant for soft-tissue augmentation: biocompatibility and chemical characterization. McClelland M; Egbert B; Hanko V; Berg RA; DeLustro F Plast Reconstr Surg; 1997 Nov; 100(6):1466-74. PubMed ID: 9385958 [TBL] [Abstract][Full Text] [Related]
29. Use of Zyderm in the aging face. Nicolle FV Aesthetic Plast Surg; 1982; 6(4):193-5. PubMed ID: 7171056 [TBL] [Abstract][Full Text] [Related]
30. Artecoll: the Arizona experience and lessons learned. Thaler MP; Ubogy ZI Dermatol Surg; 2005 Nov; 31(11 Pt 2):1566-74; discussion 1575-6. PubMed ID: 16416640 [TBL] [Abstract][Full Text] [Related]
31. Prolonged urinary retention after collagen periurethral injections: a sequela of humoral immunity. Heit M Obstet Gynecol; 1997 Oct; 90(4 Pt 2):693-5. PubMed ID: 11770601 [TBL] [Abstract][Full Text] [Related]
32. Role of injectable collagen in the treatment of glottic insufficiency: a study of 119 patients. Ford CN; Bless DM; Loftus JM Ann Otol Rhinol Laryngol; 1992 Mar; 101(3):237-47. PubMed ID: 1543333 [TBL] [Abstract][Full Text] [Related]
33. Use of injectable collagen for cosmetic lines of the face: preliminary report. Kamer F; Hunter D Laryngoscope; 1983 Jul; 93(7):950-2. PubMed ID: 6865632 [No Abstract] [Full Text] [Related]
34. ArteFill: a long-lasting injectable wrinkle filler material--summary of the U.S. Food and Drug Administration trials and a progress report on 4- to 5-year outcomes. Cohen SR; Berner CF; Busso M; Gleason MC; Hamilton D; Holmes RE; Romano JJ; Rullan PP; Thaler MP; Ubogy Z; Vecchione TR Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):64S-76S. PubMed ID: 16936546 [TBL] [Abstract][Full Text] [Related]
38. Human-derived and new synthetic injectable materials for soft-tissue augmentation: current status and role in cosmetic surgery. Alster TS; West TB Plast Reconstr Surg; 2000 Jun; 105(7):2515-25; discussion 2526-8. PubMed ID: 10845309 [TBL] [Abstract][Full Text] [Related]
39. Delayed hypersensitivity and systemic arthralgia following transurethral collagen injection for stress urinary incontinence. Stothers L; Goldenberg SL J Urol; 1998 May; 159(5):1507-9. PubMed ID: 9554343 [TBL] [Abstract][Full Text] [Related]
40. Twelve-month persistency of a novel ribose-cross-linked collagen dermal filler. Narins RS; Brandt FS; Lorenc ZP; Maas CS; Monheit GD; Smith SR Dermatol Surg; 2008 Jun; 34 Suppl 1():S31-9. PubMed ID: 18547179 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]